Johnson MedTech Middle East, the move is crucial in countries with lower bed capacity. Johnson & Johnson, the global medical technology provider, is providing digital solutions that will shorten the time spent by patients in hospitals.
The digital solutions that currently offer help to shorten the time of patients’ stay, so the capacity can absorb more patients, especially in the geographies where capacity is limited.
Johnson & Johnson MedTech provides a broad range of medical technology devices used in interventional solutions, orthopedics, and surgery. Their offerings include products to treat cardiovascular diseases, hemorrhagic and ischemic stroke, and a combination of products supporting hips, knees, trauma, spine and others.
The company’s surgery portfolios include advanced and general surgery offerings. These devices are used predominantly in the professional fields by physicians, nurses, hospitals, eyecare professionals and clinics, according to a statement issued by the company.
The company unveiled its “Get Smart About AFib” global campaign at the conference with cardiac scientists, caregivers, and several cardiac working groups to improve care and treatment for patients suffering from atrial fibrillation, or AFib.
Johnson & Johnson MedTech has been operating in the region for a couple of decades, establishing a headquarters in Riyadh back in 2017, along with two other offices in Jeddah and Dammam.
The Kingdom is allocating about 14.4 percent of its 2022 budget to healthcare and social development, which amounts to $36.8 billion, the third largest expense after education and military, according to Dubai-based Omnia Health, a global medical directory.
With life expectancy in Saudi Arabia projected to increase from 76.4 to 81.8 years by 2050 and the Kingdom’s population expected to grow to 39.4 million by 2030, increased investment in the healthcare infrastructure and innovation is necessary to drive strong growth in the Kingdom’s healthcare sector.